Title: The Asia-Pacific IVF market is estimated to garner $4 billion by 2021, registering a CAGR of 13.5% from 2015 to 2021
1In Vitro Fertilization (IVF) Asia-Pacific Market
Research Report, 2014-2020
Published Date 30-Jun-2015
No. Pages 124
2Report Description
The Asia-Pacific IVF market would exhibit a
notable growth during the forecast period,
primarily due to factors such as delayed
pregnancies, rising infertility rates due to
dysfunctional lifestyles and the emergence of
newer fertility tourism destinations. Other
factors that would propel the market growth are
rising technological advancements, use of
intra-cytoplasmic sperm injection (ICSI) and
donor egg IVF methods, which collectively boost
the success rates of conventional IVF
cycles. High costs associated with the
treatments, inadequate IVF reimbursements, low
health awareness specifically in under-developed
Asia-Pacific regions such as Nepal, Myanmar and
other ethical concerns are factors that would
restrain the market growth. The Asia-Pacific IVF
market is estimated to garner 4 billion by 2021,
registering a CAGR of 13.5 from 2015 to 2021.
3Report Description
The commercialization of cost-efficient
treatments and the emerging role of medical
tourism, mainly in developing nations across
Asia-Pacific countries would offer lucrative
growth opportunities in future. Further, growing
clinical research initiatives for the development
of novel IVF technologies would provide a dynamic
platform for growth of the Asia-Pacific IVF
market. To provide a detailed market
assessment, the report segments the Asia-Pacific
IVF market on the basis of number of IVF cycles,
end-users and a country level analysis. The
end-users market is categorized into fertility
clinics, hospitals, surgical centres and clinical
research institutes. Fertility clinics and
hospitals were the leading end-user segments,
accounting for about 5/6th of the market, in 2014.
4Report Description
Geographically, the Asia-Pacific IVF market is
segmented across India, China, Japan, Australia,
New-Zealand, Korea, Thailand and other
Asia-Pacific countries. In terms of revenue
generation, China dominates the Asia-Pacific IVF
market, owing to the rapid adoption of advanced
technologies and availability of skilled
workforce. However, the IVF market value, in
India, is set to register a promising CAGR of
15.3 from 2015 to 2021. This growth is largely
supplemented by factors such as the rising trend
of fertility tourism and wide availability of IVF
clinics. In terms of number of cycles performed,
China is the leading country accounting for a
majority of the market share and is expected to
maintain its market position throughout the
analysis period. However, the India IVF market,
in terms of number of cycles performed, would
register a promising CAGR of 13.2 during 2015 to
2021.
5Key Market Benefits
- The report provides an in-depth analysis on the
Asia-Pacific IVF market across seven major
countries with a cross sectional analysis of the
total number of IVF cycles performed, and the
total revenue generated during the forecast
period - The report helps in understanding the strategies
adopted by various IVF clinics and hospitals in
major countries , in order to capitalize on
opportunities in the Asia-Pacific IVF market - The report comprehensively analyzes the market
scenario across different countries in the Asia
Pacific region - The projections in the report are made by
analyzing the current market trends and
highlighting the market potential for the period
of 20142021, in terms of value and volume
6Key Market Segments
Asia-Pacific IVF Market By End Users (Value
and Volume)
7IVF Market By Geography
China
Australia
India
Japan
Other
8Table of Contents
Chapter 1 Introduction Chapter 2 Executive
Summary Chapter 3 Asia-pacific In-vitro
Fertilization (Ivf) Market Overview Chapter 4
Asia-pacific Ivf Market (Revenue And Number Of
Cycles)
9FOR MORE DETAILS
Visit us at
http//www.apacmarket.com/top-market/in-vitro-fert
ilization-market
Stay With Us
TELEPHONE 61-280 454 214
EMAIL help_at_apacmarket.com